{
    "url_original": "https://www.wsj.com/articles/india-aims-to-producemrnacovid-19-vaccine-this-year-11632907801?mod=world_minor_pos1",
    "url": "india-aims-to-producemrnacovid-19-vaccine-this-year-11632907801",
    "title": "India Aims to Produce mRNA Covid-19 Vaccine This Year",
    "sub_head": "Effort could boost nation’s pharmaceutical industry and ease global distribution",
    "category_1": "World",
    "category_2": "Asia",
    "time": "2021-09-29 05:30:00",
    "body": "NEW DELHI—India is preparing to produce its own mRNA-based Covid-19 vaccine by the end of the year, in what would be a scientific breakthrough for the country’s growing pharmaceutical industry and help expand the range of global production hubs for the shots.<br />A host of companies across the world are pushing to bring their own vaccines using the mRNA technology to market following the success of the  Pfizer Inc.  and  Moderna Inc.  shots. Indian firms, urged on in part by Prime Minister Narendra Modi, aim to be significant players in the new sector, with Gennova Pharmaceuticals Ltd. hoping to be the first."
}